Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03644914 · ClinicalTrials.gov registry record · NA

Enhancing Reading Skills in 1st Grade Children

A NA study, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT03644914: Completed NA study, sponsored by Columbia University.

NCT03644914 is a NA study that has completed, run by Columbia University. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03644914, a NA study, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

The purpose of the present study is to assess a reading intervention for first graders who are identified by their teachers as reading below grade level. The intervention addresses reading skills through a variety of techniques including games, play, movement exercises, music, and breaks to enhance literacy skills and reduce frustration commonly accompanying sight word recognition and phonemic decoding. Over half of elementary school students in the United States are reading below grade level compared to their same age peers. Children with poor reading skills are more likely to experience academic and behavioral problems. When students are not reading at grade level by 4th grade, they are more likely to experience future academic failure, school dropout, juvenile delinquency, teenage pregnancy, and under- or unemployment in adulthood. Traditional methods of classroom large group instruction require children to sit quietly and concentrate on small print for extended periods of time. Many children experience frustration and agitation in response to such reading demands.

Primary Outcome

The TOWRE is a measure of reading fluency and accuracy for both children and adults. The instrument consists of two subtests: sight word efficiency (108 word items) and phonemic decoding efficiency (66 word items). The subtests can be scored separately or aggregately for a total score. Scores are calculated based on the number of total words read correctly in a 45 second period. Administration requires approximately 10 minutes.

Interventions

  • BEHAVIORAL 10-week Reading Program

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2019-02-15
Est. Completion 2019-06-30
Phase NA
Columbia University

958 total trials

What the finished NCT03644914 record still lists

NCT03644914 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which 10-week Reading Program is the first listed.

NCT03644914 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03644914 about?

NCT03644914 is a clinical study titled "Enhancing Reading Skills in 1st Grade Children". The purpose of the present study is to assess a reading intervention for first graders who are identified by their teachers as reading below grade level. The intervention addresses reading skills through a variety of techniques including games, play, movement exercises, music, and breaks to enhance ...

What is the current status of trial NCT03644914?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2019-02-15. Estimated completion is 2019-06-30.

What interventions are being tested in trial NCT03644914?

The interventions under investigation include: 10-week Reading Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT03644914?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03644914's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03644914, the US trial registry maintained by the National Library of Medicine. NCT03644914 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.